Risankizumab is a humanized IgG monoclonal antibody that binds with high affinity and specificity to the p19 subunit and selectively inhibits IL-23, critical for psoriatic inflammation. In phase-3 trials (UltIMMa-1, …
Increase in sexually transmitted infection during the COVID-19 pandemic in Taiwan.
We read with great interest Balestri et al.’s report,1 which showed that the incidence of sexually transmitted infection (STI) in the lockdown period between March 9 and May 4, 2020 …
Unleashing Carbon Emissions Savings with Regular Teledermatology Clinics.
Until Covid-19, teledermatology often tended to be a service used in exceptional circumstances rather than a standard component of healthcare. At present it is vitally important in sustaining our services, …
Vitamin D Update.
The goal of this review is to provide an update in the field of vitamin D, in particular, the role of vitamin D in non-skeletal health, the complexity of providing …
Neurologic Complications Seen in Hospitalized COVID-19 Patients
Neurologic disorders tied to increased risk for in-hospital mortality
Risk for Severe COVID-19 Low With Congenital Heart Disease
Higher risk for severe disease seen with genetic syndrome, adults at advanced physiological stage
Ischemic Heart Disease Is Major Health Burden Worldwide
126.5 million people lived with IHD in 2017; burden metrics of IHD increased between 1990 and 2017
Inactivated SARS-CoV-2 Vaccine Well Tolerated in Phase 1/2 Trial
Neutralizing antibody geometric mean titers higher in vaccine group at day 42 in phase 1 trial
Autism, ADHD Linked to More Doctor, Hospital Visits by Age 1
Patterns of health care use before age 1 distinctive in autism, attention-deficit/hyperactivity disorder
Anti-VEGF Therapy May Aid Visual Acuity in Some nAMD Patients
Useful visual acuity preserved for about 20 percent of patients over their average remaining lifetime
- Page 1 of 2
- 1
- 2